DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,780,000 | -11.1% | 14,633 | -12.7% | 0.55% | +9.9% |
Q2 2022 | $4,252,000 | -8.9% | 16,770 | +5.4% | 0.50% | +7.7% |
Q1 2022 | $4,666,000 | -4.0% | 15,906 | +7.6% | 0.47% | +21.0% |
Q4 2021 | $4,862,000 | -3.1% | 14,777 | -10.4% | 0.39% | -9.8% |
Q3 2021 | $5,020,000 | +12.4% | 16,488 | -0.9% | 0.43% | +17.3% |
Q2 2021 | $4,466,000 | +17.5% | 16,642 | -1.4% | 0.36% | +13.7% |
Q1 2021 | $3,800,000 | +3.9% | 16,881 | +2.6% | 0.32% | -13.5% |
Q4 2020 | $3,656,000 | +10.5% | 16,459 | +7.1% | 0.37% | +4.2% |
Q3 2020 | $3,310,000 | -49.6% | 15,371 | -58.6% | 0.36% | -1.9% |
Q2 2020 | $6,561,000 | +10.5% | 37,106 | -13.5% | 0.36% | -2.2% |
Q1 2020 | $5,936,000 | -12.8% | 42,887 | -3.3% | 0.37% | +11.7% |
Q4 2019 | $6,805,000 | +3.7% | 44,337 | -2.4% | 0.33% | -4.3% |
Q3 2019 | $6,561,000 | -0.1% | 45,428 | -1.1% | 0.35% | 0.0% |
Q2 2019 | $6,568,000 | +1.1% | 45,953 | -6.7% | 0.35% | +6.4% |
Q1 2019 | $6,499,000 | +39.6% | 49,230 | +9.0% | 0.33% | +19.9% |
Q4 2018 | $4,656,000 | -3.9% | 45,147 | +1.3% | 0.27% | +11.0% |
Q3 2018 | $4,844,000 | +6.9% | 44,584 | -2.9% | 0.24% | -0.4% |
Q2 2018 | $4,531,000 | +1.6% | 45,914 | +0.8% | 0.25% | -0.8% |
Q1 2018 | $4,458,000 | +5.5% | 45,528 | 0.0% | 0.25% | +6.4% |
Q4 2017 | $4,226,000 | – | 45,528 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |